Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome

Clinical Endocrinology

Volumn 45, Issue 4, 1996, Pages 423-429

  Klinger, B ^a   Jensen, L T ^a   Silbergeld, A ^b   Laron, Z ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b HVIDOVRE HOSPITAL   (Denmark)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FK 780; GROWTH HORMONE; PROCOLLAGEN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BONE METABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DWARFISM; FEMALE; HORMONE RESISTANCE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029826420     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.7990809.x     Document Type: Article

References (35)

1. Abramovici, A., Josefsberg, Z., Mimouni, M., Liban, E. & Laron, Z. (1983) Histopathological features of the skin in hypopituitarism and Laron-type dwarfism. Israel Journal of Medical Sciences, 19, 515-519.
2. Amselem, S., Duquesnoy, P., Duriez, B., Dastot, F., Sobrier, M.L. & Vallix, S. (1993) Spectrum of growth hormone receptor mutations and associated haplotypes in Laron Syndrome. Human Molecular Genenics, 4, 355-359.
3. BMDP SV Statistical Software (1990) (Chief ed. W.J. Dixon). University of California Press, Los Angeles.
4. Danne, T., Gruters, A., Schuppan, D., Quantas, N., Enders, I., & Weber, B. (1989) Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders. Journal of Pediatrics, 114, 257-260.
5. Daughaday, W.H. & Rotwein, P. (1989) Insulin-like growth factors I and II, peptide, messenger ribonucleic acid and gene structure, serum, and tissue concentrations. Endocrine Reviews, 10, 68-91.
6. Eshet, R., Laron, Z., Pertzelan, A. & Dintzman, M. (1984) Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Israel Journal of Medical Sciences, 20, 8-11.
7. Godowski, P.J., Leung, D.W., Meacham, L.R., Galgani, J.P., Hellmiss, R., Keret, R., Rotwein, P.S., Parks, J.S., Laron, Z. & Wood. W.I. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proceedings of the National Academy of Sciences USA, 86, 8083-8087.
8. Jensen, L.T., Jorgensen, J.O.L., Risteli, J., Christiansen, J.S. & Lorenzen, I. (1991) Type I and III procollagen peptides in growth hormone-deficient patients, effects of increasing doses of GH. Acta Endocrinologica (Copenhagen), 124, 278-282.
9. Klinger, B., Anin, S. & Laron, Z. (1994) Two-year treatment of Laron Syndrome children with IGF-I (Abstract 032). Endocrinology and Metabolism, 1 (Suppl. B), 16 (The Growth Hormone Research Society, Denmark 1994.).
10. Klinger, B. & Laron, Z. (1994) Renal function in Laron Syndrome patients treated by insulin-like growth factor-I. Pediatric Nephrology, 8, 684-688.
11. Klinger, B. & Laron, Z. (1995) Three year IGF-I treatment of children with Laron Syndrome. Journal of Pediatric Endocrinology and Metabolism, 8, 149-158.
12. Laron, Z. (1984) Laron-type dwarfism (hereditary somatomedin deficiency): a review. In Advances in Internal Medicine and Pediatrics (eds P. Frick, G.A. von Harnack, K. Koehsiek, G.A. Martini & A. Prader A), pp. 117-150. Springer Verlag, Berlin.
13. Laron, Z. (1995) Prismatic cases: Laron Syndrome (primary growth hormone resistance). From patient to laboratory to patient. Journal of Clinical Endocrinology and Metabolism, 80, 1526-1531.
14. Laron, Z., Anin, S., Klipper-Aurbach, Y. & Klinger, B. (1992) Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet, 39, 1258-1261.
15. Laron, Z., Blum, W.F., Chatelain, P., Ranke, M., Rosenfeld, R., Savage M. & Underwood, L. (1993a) Classification of growth hormone insensitivity syndrome. Journal of Pediatrics, 122, 241.
16. Laron, Z. & Klinger, B. (1994) IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clinical Endocrinology, 41, 631-638.
17. Laron, Z., Klinger, B., Eshet, R., Kaneti, H., Karasik, A. & Silbergeld, A. (1993b) Laron Syndrome due to a post-receptor defect: response to IGF-I treatment. Israel Journal of Medical Sciences, 29, 757-763.
18. Laron, Z., Klinger, B., Silbergeld, A., Lewin, R., Erster, B. & GilAd, I. (1990) Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Acta Endocrinologica (Copenhagen), 123, 378-382.
19. Laron, Z., Pertzelan, A. & Karp, M. (1968) Pituitary dwarfism with high serum levels of growth hormone. Israel Journal of Medical Sciences, 4, 883-894.
20. Laron, Z., Pertzelan, A., Karp, M., Keret, R., Eshet, R. & Silbergeld, A. (1993c) Laron Syndrome - A unique model of IGF-I deficiency. In Lessons from Laron Syndrome (LS) 1966-1992. Pediatric Adolescent Endocrinology Volume 24 (eds Z. Laron & J.S. Parks), pp. 3-23. Karger, Basel.
21. Laron, Z., Pertzelan, A., Karp, M., Kowadlo-Silbergeld, A. & Daughaday, W. (1971) Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone. Measurement of sulfation factor, metabolic and linear growth responses. Journal of Clinical Endocrinology and Metabolism, 33, 332-342.
22. Laron, Z., Pertzelan, A. & Mannheimer, S. (1966) Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Israel Journal of Medical Sciences, 2, 152-155.
23. Lindstedt, G., Weijkum, L., Lundberg, P.A. & Albertsson-Wikland, K. (1984) Serum procollagen III as indicator of therapeutic effect in children treated for somatotropin deficiency. Clinical Chemistry, 15, 1879-1880.
24. Melkko, J., Niemi, S., Risteli, L. & Risteli J. (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clinical Chemistry, 36, 1328-1332.
25. Nilsson, A. (1995) Bone growth and metabolism in health and disease. In Limb Lengthening: For Whom, When and How? (eds Z. Laron, S. Mastragostino, C. Romano, S. Boero & A. Cohen), pp. 9-23. Freund Publishing House Ltd, London, Tel Aviv.
26. 59Val-somatomedin C. Annals of the New York Academy of Sciences, 469, 31-52.
27. Parfitt, A.M., Simons, L.S., Villanueva, A.R. & Krane, S.M. (1987) Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. Journal of Bone and Mineral Research, 2, 427-436.
28. Risteli, J., Elomaa, I., Niemi, S., Novamo, A. & Risteli L. (1993) Radioimmunoassay for the pyridoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clinical Chemistry, 39, 635-640.
29. Risteli, J., Niemi, S., Triverdi, P., Maentausta, O. Mowat, A.P. & Risteli, L. (1988) Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clinical Chemistry, 34, 715-718.
30. Risteli, J. & Risteli, L. (1989) Growth and collagen. Current Medical Literature on Growth and Growth Factors, 4, 159-164.
31. Saggese, G., Bertelloni, S., Baroncelli, G.I. & Di Nero, G. (1992) Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. European Journal of Pediatrics, 151, 764-768.
32. Scharf, A. & Laron, Z. (1972) Skull changes in pituitary dwarfism and the syndrome of familial dwarfism with high plasma immunoreactive growth hormone. Hormone and Metabolic Research, 4, 93-97.
33. Tapanainen, P., Risteli, L., Knip, M., Kaar, M.L. & Risteli, J. (1988) Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy. Journal of Clinical Endocrinology and Metabolism, 67, 1244-1249.
34. Triverdi, P., Hindmarsh, P., Risteli, J., Risteli, L., Mowat, A.P. & Brook, C.G. (1989) Growth velocity, growth hormone therapy and serum concentrations of the amino-terminal propeptide of type III procollagen. Journal of Pediatrics, 114, 225-230.
35. Triverdi, P., Risteli, J., Risteli, L., Hindmarsh, P., Brook, C. & Mowat, A. (1991) Serum concentrations of the type I and III procollagen peptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatric Research, 30, 276-280.